Company Data
RenovoRx Inc.
Ticker
RNXT
Current Price
$0.851 2.14%
Market Cap
$31.2M
Price Target
Refer to Report
Volume
159.7K
52wk Range
$0.7006 - $1.45
Overview
RenovoRx Inc is a clinical-stage biopharmaceutical company. It is focused on developing therapies for the local treatment of solid tumors and conducting a Phase 3 registrational trial for lead product candidate RenovoGem.